The trading price of Biomerica Inc (NASDAQ:BMRA) floating higher at last check on current market day and closing at $0.66, 26.29% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.54 and $0.687. In examining the 52-week price action we see that the stock hit a 52-week high of $1.35 and a 52-week low of $0.24. Over the past month, the stock has gained 101.16% in value.
Biomerica Inc, whose market valuation is $12.10 million at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
On the technical side, indicators suggest BMRA has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that BMRA’s price is currently 20.79% off the SMA20 and 60.42% off the SMA50. The RSI metric on the 14-day chart is currently showing 63.13, and weekly volatility stands at 14.67%. When measured over the past 30 days, the indicator reaches 21.44%. Biomerica Inc (NASDAQ:BMRA)’s beta value is currently sitting at -1.10, while the Average True Range indicator is currently displaying 0.10.
To see how Biomerica Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: BMRA stock’s performance was 26.29% at last check in today’s session, and -23.50% in the past year.
An evaluation of the daily trading volume of Biomerica Inc (NASDAQ:BMRA) indicates that the 3-month average is 7.86 million. However, this figure has increased over the past 10 days to an average of 0.79.
Currently, records show that 18.34 million of the company’s shares remain outstanding. The insiders hold 11.79% of outstanding shares, whereas institutions hold 8.74%. The stats also highlight that short interest as of 2024-12-31, stood at 0.36 million shares, resulting in a short ratio of 0.63 at that time. From this, we can conclude that short interest is 233.00 of the company’s total outstanding shares. It is noteworthy that short shares in December were down slightly from the previous month’s figure, which was 1.43 million. However, since the stock’s price has seen 119.93% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
